Executive summary of clinical practice guideline for the management of invasive diseases caused by Aspergillus: 2018 Update by the GEMICOMED-SEIMC/REIPI - PubMed (original) (raw)

Practice Guideline

. 2019 Oct;37(8):535-541.

doi: 10.1016/j.eimc.2018.03.018. Epub 2018 Jun 28.

[Article in English, Spanish]

Ana Alastruey-Izquierdo 2, Manuela Aguilar-Guisado 3, Jordi Carratalà 4, Carmen Castro 5, Mario Fernández-Ruiz [ 6](#full-view-affiliation-6 "Unidad de Enfermedades Infecciosas, Hospital Universitario "12 de Octubre", Instituto de Investigación Hospital "12 de Octubre" (i+12), Universidad Complutense, Madrid, Spain."), José María Aguado [ 6](#full-view-affiliation-6 "Unidad de Enfermedades Infecciosas, Hospital Universitario "12 de Octubre", Instituto de Investigación Hospital "12 de Octubre" (i+12), Universidad Complutense, Madrid, Spain."), José María Fernández 7, Jesús Fortún 8, José Garnacho-Montero 9, Joan Gavaldà 10, Carlota Gudiol 4, Jesús Guinea 11, Alicia Gómez-López 2, Patricia Muñoz 11, Javier Pemán 12, Montserrat Rovira 13, Isabel Ruiz-Camps 10, Manuel Cuenca-Estrella 2

Affiliations

Practice Guideline

Executive summary of clinical practice guideline for the management of invasive diseases caused by Aspergillus: 2018 Update by the GEMICOMED-SEIMC/REIPI

[Article in English, Spanish]

Carolina Garcia-Vidal et al. Enferm Infecc Microbiol Clin (Engl Ed). 2019 Oct.

Abstract

Aspergillus infection is a significant cause of morbi-mortality in an at-risk population. The Study Group of Fungal Infections (GEMICOMED) from the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) has reviewed announcements made in invasive aspergillosis management. We have organized our recommendations in such a way as to provide a guide in resolving different clinical situations concerning the entire spectrum of invasive diseases caused by Aspergillus in various populations. Diagnostic approach, treatment and preventions strategies are outlined. It is not our aim that these guidelines supplant clinical judgment with respect to specific patients; however, it is our objective to perform a comprehensive summary of quality of care evidence for invasive aspergillosis management in different settings.

Keywords: Aspergillosis; Aspergilosis; Isavuconazol; Isavuconazole; Manejo clínico; Monitorización de noveles; Therapeutic drug monitoring; Tratamiento; Treatment; Voriconazol; Voriconazole.

Copyright © 2018 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.

PubMed Disclaimer

Publication types

MeSH terms

LinkOut - more resources